What is ControlRad?
Headquartered in Norcross, Georgia, ControlRad specializes in the development of advanced imaging solutions designed to minimize radiation exposure during C-arm procedures. The company addresses a critical safety gap in modern medicine, providing technology that protects both patients and healthcare professionals from the cumulative risks associated with ionizing radiation. By integrating seamlessly with existing fixed and mobile imaging hardware, ControlRad has established itself as a vital player in the medical device market, focusing on enhancing safety standards in surgical and diagnostic settings. Its market position is defined by a commitment to clinical excellence and the reduction of long-term health hazards in high-frequency imaging environments.
How much funding has ControlRad raised?
ControlRad has raised a total of $22M across 3 funding rounds:
Series A
$3M
Series B
$15M
Debt
$4M
Series A (2017): $3M, investors not publicly disclosed
Series B (2019): $15M led by Questa Capital
Debt (2020): $4M supported by SVB Financial Group
Key Investors in ControlRad
Questa Capital
Questa Capital is a venture firm focused on innovative healthcare companies that aim to enhance patient experiences, reduce costs, and improve overall population health.
SVB Financial Group
SVB Financial Group provides commercial and private banking, asset management, and investment services tailored to the needs of the innovation economy.
Undisclosed Investors
What's next for ControlRad?
With the recent influx of capital, ControlRad is well-positioned to scale its commercial operations and accelerate the adoption of its radiation-reduction technology across global healthcare systems. The company is expected to leverage this financing to deepen its research and development pipeline, potentially expanding its product suite to address broader imaging safety challenges. As the medical industry increasingly prioritizes patient safety and occupational health, ControlRad's strategic focus on reducing radiation exposure aligns with broader regulatory and clinical trends. Future growth will likely center on strategic partnerships with major medical device manufacturers and the continued penetration of the hospital and ambulatory surgery center markets.
See full ControlRad company page
